Cost-effectiveness of cardiovascular disease spending

Journal of the American College of Cardiology

Volumn 60, Issue 20, 2012, Pages 2123-2124

  Miller, George ^a   Cohen, Joshua T ^a   Roehrig, Charles ^a  

^a ALTARUM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CONGESTIVE HEART FAILURE; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; HEALTH CARE COST; HEART ARRHYTHMIA; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; LETTER; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; REGISTER; RESOURCE ALLOCATION; STATISTICAL ANALYSIS;

CARDIOVASCULAR DISEASES; COST-BENEFIT ANALYSIS; HEALTH EXPENDITURES; HUMANS; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES;

EID: 84868579707     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.02.095     Document Type: Letter

References (4)

1. G. Miller, P. Hughes-Cromwick, C. Roehrig National spending on cardiovascular disease, 1996-2008 J Am Coll Cardiol 58 2011 2017 2019
2. P. Neumann, D. Greenberg Is the United States ready for QALYs? Health Affairs 28 2009 1366 1371
3. J. Cohen, P. Neumann, M. Weinstein Does preventive care save money? Health economics and the presidential candidates N Engl J Med 358 2008 661 663
4. C. Evans, M. Tavakoli, B. Crawford Use of quality adjusted life years and life years gained as benchmarks in economic evaluations: a critical appraisal Health Care Manag Sci 7 2004 43 49